Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Public ClinicalTrials.gov record NCT04055090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Study identification
- NCT ID
- NCT04055090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Helixmith Co., Ltd.
- Industry
- Enrollment
- 101 participants
Conditions and interventions
Interventions
- Long-Term Follow-Up of Patients who Received Engensis (VM202) Genetic
- Long-Term Follow-Up of Patients who Received Placebo Drug
Genetic · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2019
- Primary completion
- Jul 23, 2019
- Completion
- Jul 23, 2019
- Last update posted
- Oct 8, 2025
2019
United States locations
- U.S. sites
- 14
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Clinical Trials, Inc. | Little Rock | Arkansas | 72205 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Center for Clinical Research | San Francisco | California | 94115 | — |
| Neurological Research Institute | Santa Monica | California | 90404 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Innovative Research of West Florida | Clearwater | Florida | 33756 | — |
| University of Florida McKnight Brain Institute | Gainesville | Florida | 32611 | — |
| Clinical Research of West Florida | Tampa | Florida | 33603 | — |
| The Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Raleigh Neurology Associates, P.A. | Raleigh | North Carolina | 27607 | — |
| Nerve and Muscle Center of Texas | Houston | Texas | 77030 | — |
| EVMS (Eastern Virginia Medical School) | Norfolk | Virginia | 23510 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04055090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04055090 live on ClinicalTrials.gov.